Literature DB >> 33753937

Post-acute COVID-19 syndrome.

Ani Nalbandian1, Kartik Sehgal2,3,4, Aakriti Gupta1,5,6, Mahesh V Madhavan1,5, Claire McGroder7, Jacob S Stevens8, Joshua R Cook9, Anna S Nordvig10, Daniel Shalev11, Tejasav S Sehrawat12, Neha Ahluwalia13, Behnood Bikdeli14,5,6,15, Donald Dietz16, Caroline Der-Nigoghossian17, Nadia Liyanage-Don18, Gregg F Rosner1, Elana J Bernstein19, Sumit Mohan8, Akinpelumi A Beckley20, David S Seres21, Toni K Choueiri22,23,14, Nir Uriel1, John C Ausiello9, Domenico Accili9, Daniel E Freedberg24, Matthew Baldwin7, Allan Schwartz1, Daniel Brodie7, Christine Kim Garcia7, Mitchell S V Elkind10,25, Jean M Connors14,26, John P Bilezikian9, Donald W Landry8, Elaine Y Wan27.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in global healthcare crises and strained health resources. As the population of patients recovering from COVID-19 grows, it is paramount to establish an understanding of the healthcare issues surrounding them. COVID-19 is now recognized as a multi-organ disease with a broad spectrum of manifestations. Similarly to post-acute viral syndromes described in survivors of other virulent coronavirus epidemics, there are increasing reports of persistent and prolonged effects after acute COVID-19. Patient advocacy groups, many members of which identify themselves as long haulers, have helped contribute to the recognition of post-acute COVID-19, a syndrome characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms. Here, we provide a comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae. Finally, we discuss relevant considerations for the multidisciplinary care of COVID-19 survivors and propose a framework for the identification of those at high risk for post-acute COVID-19 and their coordinated management through dedicated COVID-19 clinics.

Entities:  

Mesh:

Year:  2021        PMID: 33753937      PMCID: PMC8893149          DOI: 10.1038/s41591-021-01283-z

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  180 in total

1.  Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.

Authors:  Hassaan Ahmed; Kajal Patel; Darren C Greenwood; Stephen Halpin; Penny Lewthwaite; Abayomi Salawu; Lorna Eyre; Andrew Breen; Rory O'Connor; Anthony Jones; Manoj Sivan
Journal:  J Rehabil Med       Date:  2020-05-31       Impact factor: 2.912

Review 2.  5-Hydroxytryptamine receptor subtypes: molecular and functional diversity.

Authors:  F Saudou; R Hen
Journal:  Adv Pharmacol       Date:  1994

3.  Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors.

Authors:  D S Hui; G M Joynt; K T Wong; C D Gomersall; T S Li; G Antonio; F W Ko; M C Chan; D P Chan; M W Tong; T H Rainer; A T Ahuja; C S Cockram; J J Y Sung
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

4.  Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up.

Authors:  Marco Ho-Bun Lam; Yun-Kwok Wing; Mandy Wai-Man Yu; Chi-Ming Leung; Ronald C W Ma; Alice P S Kong; W Y So; Samson Yat-Yuk Fong; Siu-Ping Lam
Journal:  Arch Intern Med       Date:  2009-12-14

Review 5.  Extrapulmonary manifestations of COVID-19.

Authors:  Aakriti Gupta; Mahesh V Madhavan; Kartik Sehgal; Nandini Nair; Shiwani Mahajan; Tejasav S Sehrawat; Behnood Bikdeli; Neha Ahluwalia; John C Ausiello; Elaine Y Wan; Daniel E Freedberg; Ajay J Kirtane; Sahil A Parikh; Mathew S Maurer; Anna S Nordvig; Domenico Accili; Joan M Bathon; Sumit Mohan; Kenneth A Bauer; Martin B Leon; Harlan M Krumholz; Nir Uriel; Mandeep R Mehra; Mitchell S V Elkind; Gregg W Stone; Allan Schwartz; David D Ho; John P Bilezikian; Donald W Landry
Journal:  Nat Med       Date:  2020-07-10       Impact factor: 53.440

6.  SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes.

Authors:  Waradon Sungnak; Ni Huang; Christophe Bécavin; Marijn Berg; Rachel Queen; Monika Litvinukova; Carlos Talavera-López; Henrike Maatz; Daniel Reichart; Fotios Sampaziotis; Kaylee B Worlock; Masahiro Yoshida; Josephine L Barnes
Journal:  Nat Med       Date:  2020-04-23       Impact factor: 53.440

7.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

8.  Characterization of the Inflammatory Response to Severe COVID-19 Illness.

Authors:  Oliver J McElvaney; Natalie L McEvoy; Oisín F McElvaney; Tomás P Carroll; Mark P Murphy; Danielle M Dunlea; Orna Ní Choileáin; Jennifer Clarke; Eoin O'Connor; Grace Hogan; Daniel Ryan; Imran Sulaiman; Cedric Gunaratnam; Peter Branagan; Michael E O'Brien; Ross K Morgan; Richard W Costello; Killian Hurley; Seán Walsh; Eoghan de Barra; Cora McNally; Samuel McConkey; Fiona Boland; Sinead Galvin; Fiona Kiernan; James O'Rourke; Rory Dwyer; Michael Power; Pierce Geoghegan; Caroline Larkin; Ruth Aoibheann O'Leary; James Freeman; Alan Gaffney; Brian Marsh; Gerard F Curley; Noel G McElvaney
Journal:  Am J Respir Crit Care Med       Date:  2020-09-15       Impact factor: 21.405

9.  Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors.

Authors:  So Hee Lee; Hyoung-Shik Shin; Hye Yoon Park; Jeong Lan Kim; Jung Jae Lee; Haewoo Lee; Sung-Doo Won; Woori Han
Journal:  Psychiatry Investig       Date:  2019-01-07       Impact factor: 2.505

10.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

View more
  803 in total

1.  The four most urgent questions about long COVID.

Authors:  Michael Marshall
Journal:  Nature       Date:  2021-06       Impact factor: 49.962

2.  Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.

Authors:  Manuela Funke-Chambour; Pierre-Olivier Bridevaux; Christian F Clarenbach; Paola M Soccal; Laurent P Nicod; Christophe von Garnier
Journal:  Respiration       Date:  2021-06-04       Impact factor: 3.580

3.  Long-COVID Headache.

Authors:  Paolo Martelletti; E Bentivegna; V Spuntarelli; M Luciani
Journal:  SN Compr Clin Med       Date:  2021-05-20

4.  Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series.

Authors:  Sherif M Shoucri; Lawrence Purpura; Clare DeLaurentis; Matthew A Adan; Deborah A Theodore; Alexandria Lauren Irace; Shelief Y Robbins-Juarez; Apurva M Khedagi; Daniel Letchford; Amro A Harb; Lillian M Zerihun; Kate E Lee; Karen Gambina; Max C Lauring; Noah Chen; Colin P Sperring; Sanket S Mehta; Ellen L Myers; Hueyjong Shih; Michael G Argenziano; Samuel L Bruce; Cody L Slater; Jonathan R Tiao; Karthik Natarajan; George Hripcsak; Ruijun Chen; Michael T Yin; Magdalena E Sobieszczyk; Delivette Castor; Jason E Zucker
Journal:  BMJ Open       Date:  2021-06-02       Impact factor: 2.692

Review 5.  Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient.

Authors:  Stela Hrkac; Grgur Salai; Lovorka Grgurevic; Rudjer Novak; Simeon Grazio
Journal:  Rheumatol Int       Date:  2021-06-10       Impact factor: 2.631

6.  Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism.

Authors:  Adrian Whiting; Jonathan Vincent M Reyes; Saad Ahmad; Joseph Lieber
Journal:  Cureus       Date:  2021-05-03

Review 7.  Post-COVID Syndrome: An Insight on Its Pathogenesis.

Authors:  Helena C Maltezou; Androula Pavli; Athanasios Tsakris
Journal:  Vaccines (Basel)       Date:  2021-05-12

8.  Ocular findings among patients surviving COVID-19.

Authors:  Fernando Bellissimo-Rodrigues; Rosalia Antunes-Foschini; Ílen Ferreira Costa; Livia Pimenta Bonifácio; Eduardo Melani Rocha; Rodrigo Jorge; Valdes Roberto Bollela
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

9.  Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors.

Authors:  Dominic Paquin-Proulx; Bronwyn M Gunn; Aljawharah Alrubayyi; Danielle V Clark; Matthew Creegan; Dohoon Kim; Hannah Kibuuka; Monica Millard; Salim Wakabi; Leigh Anne Eller; Nelson L Michael; Randal J Schoepp; Matthew J Hepburn; Lisa E Hensley; Merlin L Robb; Galit Alter; Michael A Eller
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

10.  ["Long-haul COVID": An opportunity to address the complexity of post-infectious functional syndromes].

Authors:  P Cathébras; J Goutte; B Gramont; M Killian
Journal:  Rev Med Interne       Date:  2021-06-09       Impact factor: 0.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.